CD4 and cancer: Further immune cell infiltration analysis revealed that cancer-associated fibroblasts (XCELL), CD4+ T cells (TIMER), uncharacterized cells (QUANTISEQ), CD8+ T cells (EPIC), as well as M2 macrophages and resting mast cells (CIBERSORT) were positively correlated with the risk score.